You are here: Home » 2023 » April » Archives for 13th

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important April 25 Deadline in Securities Class Action – CTLT

NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. (NYSE: CTLT) between August 30, 2021 and October 31, 2022, both dates inclusive (the "Class Period"), of the important April 25, 2023, lead plaintiff deadline.

SO WHAT: If you purchased Catalent securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Catalent class action, go to https://rosenlegal.com/submit–form/?case_id=12490 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 25, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated its revenue and earnings by prematurely recognizing revenue in violation of U.S. Generally Accepted Accounting Principles ("GAAP"); (2) the Company had material weaknesses in its internal control over financial reporting related to revenue recognition; (3) the Company falsely represented demand for its products while it knowingly sold more product to its direct customers than could be sold to healthcare providers and end consumers; (4) the Company disregarded regulatory rules at key production facilities in order to rapidly produce excess inventory that was used to pad the Company's financial results through premature revenue recognition in violation of GAAP and/or stuffing its direct customers with this excess inventory; and (5) as a result of the foregoing, defendants lacked a reasonable basis for their positive statements about the Company's financial performance, outlook and regulatory compliance during the Class Period. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Catalent class action, go to https://rosenlegal.com/submit–form/?case_id=12490 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8807558)

Centro Semillero Offers Two Master's Programs and Endless Possibilities

Houston, Texas, April 13, 2023 (GLOBE NEWSWIRE) — You may have heard the motto, “Those who dare to teach must never cease to learn.” This principle strongly applies to two Houston–area educators who, through Centro Semillero at University of St. Thomas–Houston (UST), have confirmed their callings as teachers and fortified their faith. Moreover, they are applying the academic program's four pillars "" kindness, discipline, knowledge, and community "" to everything they do.

Angel de Jesus Garcia, Current Master's Student

One of them is Angel de Jesus Garcia, a college advisor at Houston Independent School District and currently enrolled in Centro Semillero's Master of Sacred Scriptures Program.

“When my friends told me that St. Thomas was about to launch a master's degree program in Spanish, I went to orientation and decided to give it try," Garcia said. "That's how I became part of the first generation of Spanish–speaking theology students, and I thank God for that decision.”

Garcia made this decision because it perfectly supported both his profession as an educator and his after–work role as a leader at his parish's youth ministry where he attends pastoral meetings, plans retreats, and creates Christian formation programs.

About Centro Semillero

Centro Semillero was created in 2019 as a graduate studies program in pastoral and biblical studies theology at the UST School of Humanities. Offered online and 100% in Spanish, Centro Semillero offers two postgraduate programs: a Master's in Pastoral Theology and a Master's in Sacred Scriptures.

“Centro Semillero,” according to its director Father Dempsey Rosales Acosta, "is inspired by the book of Proverbs 2:2–3 when fulfilling the invitation to incline our hearts to the understanding and study of God to grow in his love. Our center offers the opportunity to fulfill this goal of personal and professional growth by obtaining a postgraduate degree in pastoral or biblical studies at UST from the comfort of your home with our 100% online programs.”

Iris Lai Nayas, MAPT "21

For Iris Lai Nayas, a 9th–grade Spanish teacher at Pasadena Independent School District, and a graduate of the Pastoral Theology program in 2021, the concepts she learned have opened a door for dialogue with colleagues from other religions.

Nayas said, “The program has helped me find pastoral strategies for interacting with my colleagues, who are not necessarily Catholic. The strategies enable me to dialogue with all of my colleagues and live experiences of faith without losing the essence of mine.”

Most importantly, the program has made her realize that through her interactions with her students and peers, she can be a testament to God's presence.

“Today, schools they have taken God out of the classroom but thanks to this program, I understand that God has never been outside, and it is up to me to present him, through values, justice, love, prudence, prayer, and faith,” adds Nayas.

Thanks to her graduate degree, Nayas is also a facilitator in the Small Communities of Salt and Light of Maryknoll Fathers and Brothers.

How to Enroll

Centro Semillero has open enrollment for new students. To learn more about Centro Semillero click here.

Attachments


GLOBENEWSWIRE (Distribution ID 8807777)

Nyxoah Lève 3 Millions de Dollars dans le Cadre de son Offre d'Actions At-The-Market

INFORMATIONS PRIVILGIES
INFORMATIONS RGLEMENTES

Nyxoah Lve 3 Millions de Dollars dans le Cadre de son Offre d'Actions At–The–Market

Mont–Saint–Guibert, Belgique "" 13 Avril 2023, 22h05 CET / 16h05 ET "" Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) ( Nyxoah ou la Socit ) opre dans le secteur des technologies mdicales et se concentre sur le dveloppement et la commercialisation de solutions innovantes destines traiter le Syndrome d'Apnes Obstructives du Sommeil (SAOS). La Socit a annonc aujourd'hui que la Socit a lev un produit brut de 3 millions de dollars dans le cadre de son programme de 50 millions de dollars At–The–Market (“ATM”) tabli le 22 dcembre 2022 un prix d'mission gal au prix du march sur le Nasdaq Global Market au moment de la vente. Le produit de cette leve de fonds sera utilis des fins gnrales.

Les actions ordinaires dcrites ci–dessus ont t vendues conformment la dclaration d'enregistrement pralable de la Socit sur le formulaire F–3 (dossier n . 333–268955), prcdemment dpose auprs de la Securities and Exchange Commission (“SEC”) le 22 dcembre 2022, qui est entre en vigueur le 6 janvier 2023, et d'un supplment de prospectus dat du 6 janvier 2023 et du prospectus d'accompagnement que la Socit a dpos auprs de la SEC dans le cadre de l'offre et de la vente des actions ordinaires de la Socit conformment l'accord de vente Controlled Equity OfferingSM, dat du 22 dcembre 2022 et conclu avec Cantor Fitzgerald & Co, en tant qu'agent de vente (prospectus@cantor.com).

propos de Nyxoah
Nyxoah opre dans le secteur des technologies mdicales. Elle se concentre sur le dveloppement et la commercialisation de solutions innovantes destines traiter le Syndrome d'Apnes Obstructives du Sommeil (SAOS). La principale solution de Nyxoah est le systme Genio , une thrapie de neurostimulation du nerf hypoglosse sans sonde et sans batterie qui a reu le marquage CE, centre sur le patient et destine traiter le Syndrome d'Apnes Obstructives du Sommeil (SAOS), le trouble respiratoire du sommeil le plus courant au monde. Ce dernier est associ un risque accru de mortalit et des comorbidits, dont les maladies cardiovasculaires. La visions de Nyxoah est que les patients souffrant de SAOS doivent pouvoir profiter de nuits rparatrices et vivre pleinement leur vie.

la suite de la finalisation probante de l'tude BLAST OSA, le systme Genio a reu le marquage europen CE en 2019. Nyxoah a ralis avec succs deux IPO : l'une sur Euronext Bruxelles en septembre 2020 et l'autre sur le NASDAQ en juillet 2021. Grce aux rsultats positifs de l'tude BETTER SLEEP, Nyxoah a reu le marquage CE pour l'extension de ses indications thrapeutiques aux patients souffrant de collapsus concentrique complet (CCC), pour lesquels les thrapies concurrentes sont actuellement contre–indiques. En outre, la Socit mne actuellement l'tude pivot IDE DREAM pour la FDA obtenir l'autorisation de mise sur le march.

Attention "" marquage CE depuis 2019. Dispositif de recherche aux tats–Unis. Limit un usage exprimental aux tats–Unis par la loi fdrale amricaine.

DCLARATIONS PROSPECTIVES

Certaines dclarations, croyances et opinions contenues dans le prsent communiqu de presse sont de nature prospective et refltent les attentes actuelles de la socit ou, le cas chant, des administrateurs ou de la direction de la socit concernant le systme Genio , les tudes cliniques prvues et en cours sur le systme Genio , les avantages potentiels du systme Genio ; les objectifs de Nyxoah en ce qui concerne le dveloppement, la voie rglementaire et l'utilisation potentielle du systme Genio ; l'utilit des donnes cliniques pour l'obtention ventuelle de l'approbation du systme Genio par la FDA ; et les rsultats d'exploitation, la situation financire, les liquidits, les performances, les perspectives, la croissance et les stratgies de la socit. De par leur nature, les dclarations prvisionnelles impliquent un certain nombre de risques, d'incertitudes, d'hypothses et d'autres facteurs qui pourraient faire en sorte que les rsultats ou vnements rels diffrent matriellement de ceux exprims ou sous–entendus dans les dclarations prvisionnelles. Ces risques, incertitudes, hypothses et facteurs pourraient avoir une incidence ngative sur les rsultats et les effets financiers des plans et des vnements dcrits dans le prsent document. En outre, ces risques et incertitudes comprennent, sans s'y limiter, les risques et incertitudes noncs dans la section “Facteurs de risque” du rapport annuel de la socit sur le formulaire 20–F pour l'exercice clos le 31 dcembre 2022, dpos auprs de la Securities and Exchange Commission (“SEC”) le 22 mars 2023, et des rapports ultrieurs que la socit dpose auprs de la SEC. Une multitude de facteurs, y compris, mais sans s'y limiter, les changements dans la demande, la concurrence et la technologie, peuvent faire en sorte que les vnements, les performances ou les rsultats rels diffrent de manire significative de tout dveloppement anticip. Les dclarations prospectives contenues dans le prsent communiqu de presse concernant des tendances ou des activits passes ne constituent pas des garanties de performances futures et ne doivent pas tre considres comme une dclaration selon laquelle ces tendances ou activits se poursuivront l'avenir. En outre, mme si les rsultats ou dveloppements rels sont conformes aux dclarations prospectives contenues dans le prsent communiqu de presse, ces rsultats ou dveloppements peuvent ne pas tre reprsentatifs des rsultats ou dveloppements des priodes futures. Aucune dclaration ou garantie n'est donne quant l'exactitude ou la justesse de ces dclarations prospectives. En consquence, la socit dcline expressment toute obligation ou tout engagement de publier des mises jour ou des rvisions des dclarations prospectives contenues dans le prsent communiqu de presse la suite d'un changement des attentes ou d'un changement des vnements, conditions, hypothses ou circonstances sur lesquels ces dclarations prospectives sont bases, sauf si la loi ou la rglementation l'exige expressment. Ni la Socit, ni ses conseillers ou reprsentants, ni aucune de ses filiales, ni les dirigeants ou employs de ces personnes ne garantissent que les hypothses sous–jacentes ces dclarations prospectives sont exemptes d'erreurs et n'acceptent aucune responsabilit quant l'exactitude future des dclarations prospectives contenues dans ce communiqu de presse ou quant la survenance effective des dveloppements prvus. Vous ne devriez pas accorder une confiance excessive aux dclarations prospectives, qui ne sont valables qu' la date du prsent communiqu de presse.

Contacts :
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Pice jointe


GLOBENEWSWIRE (Distribution ID 1000803834)

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Raises $3 Million from its At–the–Market Equity Offering

Mont–Saint–Guibert, Belgium "" April 13, 2023, 10:05pm CET / 4:05pm ET "" Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $3.0 million in gross proceeds pursuant to the Company's $50 million at–the–market (“ATM”) program established on December 22, 2022 at an issue price equal to the market price on the Nasdaq Global Market at the time of the sale. The proceeds will be used for general corporate purposes.

The ordinary shares described above were sold pursuant to the Company's shelf registration statement on Form F–3 (File No. 333–268955), previously filed with the Securities and Exchange Commission ("SEC") on December 22, 2022, which became effective on January 6, 2023, and a prospectus supplement dated January 6, 2023 and the accompanying prospectus the Company filed with the SEC in connection with the offer and sale of the Company's common stock pursuant to the Controlled Equity OfferingSM Sales Agreement, dated as of December 22, 2022 with Cantor Fitzgerald & Co., as sales agent (prospectus@cantor.com).

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah's lead solution is the Genio system, a patient–centered, leadless and battery–free hypoglossal neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors' therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

Caution "" CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

FORWARD–LOOKING STATEMENTS

Certain statements, beliefs and opinions in this press release are forward–looking, which reflect the Company's or, as appropriate, the Company directors' or managements' current expectations regarding the Genio system; planned and ongoing clinical studies of the Genio system; the potential advantages of the Genio system; Nyxoah's goals with respect to the development, regulatory pathway and potential use of the Genio system; the utility of clinical data in potentially obtaining FDA approval of the Genio system; and the Company's results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward–looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward–looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the "Risk Factors" section of the Company's Annual Report on Form 20–F for the year ended December 31, 2022, filed with the Securities and Exchange Commission ("SEC") on March 22, 2023, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward–looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward–looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward–looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward–looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward–looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward–looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward–looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment


GLOBENEWSWIRE (Distribution ID 1000803834)

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Alphabet Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – GOOG, GOOGL

NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alphabet Inc. (NASDAQ: GOOG, GOOGL), the parent company of Google, between February 4, 2020 and January 23, 2023, both dates inclusive (the "Class Period"), of the important May 15, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Alphabet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Alphabet class action, go to https://rosenlegal.com/submit–form/?case_id=13312 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 15, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Alphabet used its dominance in the field of digital advertising to disadvantage website publishers and advertisers who used competing advertising products; (2) the foregoing conduct was anticompetitive in nature and likely to draw significant regulatory scrutiny; (3) Alphabet's revenues were unsustainable to the extent that they were the product of said anticompetitive conduct; (4) Alphabet's conduct, once revealed, would negatively impact the Company's reputation and expose it to a heightened risk of litigation and regulatory enforcement action; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Alphabet class action, go to https://rosenlegal.com/submit–form/?case_id=13312 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8807550)

ALCO DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alico, Inc. Investors to Secure Counsel Before Important April 18 Deadline in Securities Class Action – ALCO

NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alico, Inc. (NASDAQ: ALCO) between February 4, 2021 and December 13, 2022, both dates inclusive (the "Class Period"), of the important April 18, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Alico securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Alico class action, go to https://rosenlegal.com/submit–form/?case_id=13493 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 18, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Alico had deficient disclosure controls and procedures and internal control over financial reporting; (2) as a result, the Company had improperly calculated Alico's deferred tax liabilities over a multi–year period; (3) accordingly, the Company would likely be required to restate one or more of its previously issued financial statements; (4) the foregoing would impede the timely completion of the audit of the Company's financial results in advance of its year–end earnings call; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Alico class action, go to https://rosenlegal.com/submit–form/?case_id=13493 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8807528)

ROSEN,A LONGSTANDING LAW FIRM, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMGN

NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. (NASDAQ: AMGN) between July 29, 2020 and April 27, 2022, both dates inclusive (the "Class Period"), of the important May 12, 2023.

SO WHAT: If you purchased Amgen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Amgen class action, go to https://rosenlegal.com/submit–form/?case_id=13114 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 12, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the U.S. government claimed Amgen owed more than $3 billion in back taxes for tax years 2010, 2011, and 2012; (2) the U.S. government claimed Amgen owed more than $5 billion in back taxes for tax years 2013, 2014, and 2015; (3) the U.S. government would likely claim Amgen owed materially more to the U.S. government than investors had been led to believe for subsequent tax years for which the Company had used the same profit allocation treatment between its U.S. and Puerto Rico operations; (4) Amgen had not taken sufficient accruals to account for its outstanding tax liabilities; (5) Amgen had failed to comply with ASC 450 and other rules and regulations regarding the preparation of its periodic SEC filings; and (6) Amgen's refusal to pay taxes claimed by the U.S. government exposed the Company to a substantial risk of severe financial penalties imposed by the IRS. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Amgen class action, go to https://rosenlegal.com/submit–form/?case_id=13114 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8807554)

Escalent adquire C Space, Hall & Partners

DETROIT, April 13, 2023 (GLOBE NEWSWIRE) — A Escalent, principal empresa de anlise e consultoria de dados, anunciou hoje que adquiriu a C Space e a Hall & Partners da Omnicom. Como principais parceiros de algumas das marcas mais excepcionais do mundo, a Escalent, a C Space e a Hall & Partners tm ajudado na inovao, aprimoramento e navegao e orientao da disrupo h anos. Elas esto se unindo para criar uma parceria maior, mais forte e mais capaz das principais empresas do mundo, por meio da unio da profunda experincia do setor em marcas, clientes e produtos em uma plataforma de insights do mercado global, focada em ajudar os clientes a encontrarem novas fontes de crescimento.

Juntas, as organizaes conquistaram o status de parceiras confiveis das principais marcas do mundo em setores de rpido crescimento, incluindo Automotivo e Mobilidade, Bens de Consumo e Varejo, Servios Financeiros, Sade e Tecnologia, bem como Energia, Telecomunicaes, e Viagens e Turismo.

"Esta unio tem por base uma experincia incomparvel no que impulsiona os seres humanos, culturas e mercados – um entendimento que torna nossa equipe parceiros incrivelmente valiosos e posiciona nossos clientes para o sucesso no ambiente acelerado e em constante mudana dos negcios de hoje", disse Melissa Sauter, CEO da Escalent. "A nossa parceria viabiliza um tremendo potencial de crescimento para nossos funcionrios, clientes e acionistas de todo o mundo."

A Hall & Partners contribui com uma excelente franquia de pesquisa e gerenciamento de marca, juntamente com sua tecnologia proprietria, incluindo uma plataforma de gesto de conhecimento de marca premiada para a nova parceria. A C Space contribui com uma soluo lder de mercado para a criao de comunidades e relacionamentos com clientes, e a Escalent contribui com uma forte plataforma global com profundo conhecimento do setor, e recursos avanados em pesquisa e anlise secundrias. A nova empresa cria uma forte presena global com quase 2.000 consultores, pesquisadores, cientistas de dados, tecnlogos e especialistas operacionais em 20 pases.

"Esta aquisio uma grande vitria para os nossos funcionrios", acrescentou a CEO da C Space, Jessica DeVlieger. "Nossas empresas tm viso de futuro e oferecem aos funcionrios a oportunidade de nutrir seu crescimento profissional por meio de produtos e servios expandidos que tm um impacto real nos nossos clientes, em um ambiente que engrandece a diversidade e reconhece as valiosas contribuies de cada membro da equipe."

"Ao longo do prximo ano, as equipes das empresas iro trabalhar em conjunto para desenvolver um plano detalhado para que nossos clientes e funcionrios estejam cientes dos benefcios da nossa empresa conjunta", disse Tim Wragg, CEO da Hall & Partners. "Estamos prontos para oferecer recursos profundos e tecnologia de ponta, e nos dedicar ao relacionamento pessoal com os clientes. Estamos ansiosos para comear a trabalhar em direo ao nosso futuro."

DeVlieger e Wragg continuaro a liderar suas empresas como parte da equipe de liderana executiva da Sauter. Os clientes continuaro a trabalhar com as mesmas equipes experientes e no temos nenhum plano de curto prazo de alterar os locais da empresa ou combinar as identidades das marcas.

"Estamos muito entusiasmados em reunir esses recursos incrveis em um lder global focado e dedicado pesquisa e aos insights da mais alta qualidade para os nossos clientes. Juntas, as empresas criam um fantstico e profundo conjunto de conhecimentos com escala e capacidade de crescimento, enquanto focadas em uma misso central compartilhada. Como tal, a nova empresa continuar a se diferenciar diante dos seus clientes por meio de insights e parcerias excepcionais", disse J.T. Treadwell, Diretor Administrativo da STG, patrocinador financeiro da Escalent.

Sobre a Escalent
A Escalent uma empresa premiada de anlise de dados e consultoria especializada em indstrias que enfrentam disrupo e transformao de negcios. H mais de 40 somos catalisadores do progresso, com a acelerao do crescimento por meio da criao de um fluxo contnuo de dados de negcios primrios, secundrios, sindicados e internos, com fornecimento de servios de consultoria, abrangendo desde os insights at implementao. A Escalent est sediada em Livonia, Michigan, com locais nos EUA e no Canad, China, ndia, Irlanda, Filipinas, Cingapura, frica do Sul, Emirados rabes Unidos e Reino Unido. Visite escalent.co para ver como estamos ajudando a moldar as marcas que esto remodelando o mundo.

Sobre a C Space

A C Space uma agncia global de insight, estratgia e inovao que desenvolve os clientes de acordo com a maneira como as empresas trabalham. Em parceria com as marcas mais conhecidas do mundo, incluindo Walmart, McDonald's, IKEA e muitas outras, a C Space ajuda os clientes a desbloquear o crescimento atravs do poder das relaes humanas – co–criando com os clientes, em vez de para eles, para maior relevncia, fidelidade mais profunda e maior valor ao longo da vida do cliente. As solues completas de servio de atendimento ao cliente da C Space so adaptadas para atender a necessidades especficas da empresa, com foco em comunidades online privadas, eventos de co–criao, workshops e potente narrativa e ativao de insights. Com sede em Boston, a C Space tem escritrios em Londres, Nova York, So Francisco e Cidade do Mxico.

Sobre a Hall & Partners

A Hall & Partners uma equipe de pensadores no convencionais, dedicada forma como o marketing influencia a relao entre pessoas, marcas e cultura. Nascida da Adland, somos a agncia de insights conhecida por unir a criatividade cincia. Extramos os dados atravs de uma lente estratgica para revelar "insights incomuns" "" verdades humanas adaptadas a marcas individuais, e no dados genricos disponveis para as massas. Fazemos parcerias com clientes para moldar a estratgia da marca e otimizar o desempenho da marca e da campanha. Nossa abordagem premiada amplifica os insights em todas as reas dos negcios, impulsionando a tomada de decises de marketing para a criao de uma vantagem competitiva incomparvel. Com sede em Londres, a Hall & Partners tem escritrios em Nova York, Los Angeles e Chicago.

Fotos deste comunicado podem ser encontradas em:

https://www.globenewswire.com/NewsRoom/AttachmentNg/a9fa10fe–a141–4ab5–9823–af7a6ccf35c3

https://www.globenewswire.com/NewsRoom/AttachmentNg/fd85618f–f66f–4b47–957b–53e9fb689ffb


GLOBENEWSWIRE (Distribution ID 8806616)

ROSEN, A LEADING NATIONAL FIRM, Encourages BlockFi Interest Account Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against Zac Prince, Flori Marquez, Amit Cheela, David Olsson, and Samia Bayou

NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds investors in BlockFi Interest Accounts ("BIAs") between March 4, 2019 and November 28, 2022, inclusive (the "Class Period"), against Zac Prince, Flori Marquez, Amit Cheela, David Olsson, and Samia Bayou (together, "Defendants"), of the important May 1, 2023 lead plaintiff deadline.

SO WHAT: If you invested in BlockFi Interest Accounts ("BIAs") during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the BlockFi class action, go to https://rosenlegal.com/submit–form/?case_id=12656 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 1, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Defendants made false and misleading statements to promote BlockFi Interest Accounts ("BIAs"), including that BIAs were a secure method of collecting interest. In addition, the Complaint alleges, among other things, that the defendants omitted and concealed material information concerning the risks associated with BIAs, including through BlockFi's exposure to FTX Trading, Ltd. ("FTX") and Sam Bankman–Fried's trading firm Alameda Research ("Alameda"), both of which collapsed in the wake of revelations that FTX and Alameda were engaging in fraud on a massive scale. In the wake of the FTX collapse, the lawsuit alleges that BlockFi froze withdrawals in BIAs, harming BIA investors. Further, investors in BIAs were not aware of conflicts of interest and self–dealing between BlockFi and other entities, such as Gemini Trust LLC, controlled by Tyler and Cameron Winklevoss. The Complaint further alleges BlockFi and the Individual Defendants engaged in the unlawful offer and sale of securities in violation of Sections 5, 11, 12(a)(2), and 15 of the Securities Act of 1933 by selling BIAs to investors. The lawsuit also alleges claims for violation of Section 10(b) and 20 of the Securities Exchange Act of 1934 and Massachusetts General Law Chapter 110A.

To join the BlockFi class action, go to https://rosenlegal.com/submit–form/?case_id=12656 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8807527)

Escalent übernimmt C Space, Hall & Partners

DETROIT, April 13, 2023 (GLOBE NEWSWIRE) — Das fhrende Datenanalyse– und Beratungsunternehmen Escalent hat heute bekannt gegeben, dass es C Space und Hall & Partners von Omnicom bernommen hat. Als fhrende Partner einiger weltweit herausragender Marken untersttzen Escalent, C Space und Hall & Partners Unternehmen seit Jahren dabei, Innovationen zu entwickeln, zu verbessern und Umwlzungen zu bewltigen. Nun schlieen sie sich zusammen, um einen greren, strkeren und leistungsfhigeren Partner fr die weltweit fhrenden Unternehmen zu schaffen, der tiefgreifende Branchenkenntnisse ber Marken, Kunden und Produkte auf einer fokussierten, globalen Plattform fr Marktinformationen vereint, um Kunden bei der Erschlieung neuer Wachstumsquellen zu untersttzen.

Gemeinsam haben sich die Organisationen den Status eines vertrauenswrdigen Partners fr die weltweit fhrenden Marken in schnell wachsenden Branchen wie Automobil und Mobilitt, Konsumgter und Einzelhandel, Finanzdienstleistungen, Gesundheit und Technologie sowie Energie, Telekommunikation, Reisen und Tourismus erarbeitet.

"Diese Vereinigung basiert auf einem unbertroffenen Fachwissen darber, was Menschen, Kulturen und Mrkte antreibt "" ein Verstndnis, das unser Team zu unglaublich wertvollen Partnern macht und unsere Kunden in der heutigen schnelllebigen, sich stndig verndernden Geschftswelt zum Erfolg fhrt", so Escalent CEO Melissa Sauter. "Gemeinsam bieten wir unseren Mitarbeitern, Kunden und Aktionren in aller Welt enormes Wachstumspotenzial."

Hall & Partners bringt ein exzellentes Forschungs– und Markenmanagement–Franchise zusammen mit einer proprietren Technologie, einschlielich einer preisgekrnten Plattform fr das Management von Markenwissen, in die Vereinigung ein. C Space bringt die marktfhrende Lsung fr den Aufbau von Communities und Kundenbeziehungen ein, whrend Escalent eine starke globale Plattform mit fundierten Branchenkenntnissen und fortschrittlichen Fhigkeiten in der Sekundrforschung und Analytik beisteuert. Die kombinierte Organisation schafft eine starke globale Prsenz mit fast 2.000 Beratern, Forschern, Datenwissenschaftlern, Technologen und operativen Experten in 20 Lndern.

"Diese bernahme ist ein groer Gewinn fr unsere Mitarbeiter", fgte Jessica DeVlieger, CEO von C Space, hinzu. "Unsere Unternehmen sind zukunftsorientiert und bieten ihren Mitarbeitern die Mglichkeit, sich beruflich weiterzuentwickeln. Dies wird ermglicht durch erweiterte Produkte und Dienstleistungen, die fr unsere Kunden von echtem Nutzen sind, und in einem Umfeld, das Vielfalt frdert und die wertvollen Beitrge jedes einzelnen Teammitglieds anerkennt."

"Im Laufe des kommenden Jahres werden unternehmensbergreifende Teams zusammenarbeiten, um einen durchdachten Plan zu entwickeln, der sicherstellt, dass unsere Kunden und Mitarbeiter von den Vorteilen unserer gemeinsamen Organisation profitieren", sagte Tim Wragg, CEO von Hall & Partners. "Wir sind perfekt ausgewogen, um umfassende Ressourcen und fhrende Technologien anzubieten und gleichzeitig persnliche Kundenbeziehungen zu pflegen. Wir sind begierig darauf, mit der Arbeit an unserer Zukunft zu beginnen."

DeVlieger und Wragg werden ihre Unternehmen weiterhin als Teil des Fhrungsteams von Sauter leiten. Die Kunden werden weiterhin mit denselben erfahrenen Teams zusammenarbeiten, und es gibt auf kurze Sicht keine Plne, die Unternehmensstandorte zu wechseln oder die Markenidentitten zusammenzufhren.

"Wir freuen uns sehr, diese erstaunlichen Fhigkeiten in einem fokussierten, aber dennoch weltweit fhrenden Unternehmen zu vereinen, das sich der Aufgabe verschrieben hat, unseren Kunden Forschung und Erkenntnisse von hchster Qualitt zu bieten. Zusammen bilden die Unternehmen eine fantastische Kombination aus fundiertem Fachwissen, Grenvorteilen und Wachstumskapazitten, whrend sie sich gleichzeitig auf eine gemeinsame Kernaufgabe konzentrieren. Dementsprechend macht auch die kombinierte Organisation durch auergewhnliche Erkenntnisse und Partnerschaften fr ihre Kunden einen Unterschied", so J.T. Treadwell, Managing Director bei STG, dem Finanzsponsor von Escalent.

ber Escalent
Escalent ist ein preisgekrntes Datenanalyse– und Beratungsunternehmen, das sich auf Branchen spezialisiert hat, die vor Umwlzungen und geschftlichen Vernderungen stehen. Als Katalysatoren des Fortschritts seit mehr als 40 Jahren beschleunigen wir das Wachstum, indem wir einen nahtlosen Fluss zwischen primren, sekundren, syndizierten und internen Geschftsdaten schaffen und Beratungs– und Betreuungsdienste von der Erkenntnis bis zur Umsetzung anbieten. Escalent hat seinen Hauptsitz in Livonia, Michigan, und verfgt ber Niederlassungen in den USA sowie in Kanada, China, Indien, Irland, auf den Philippinen, in Singapur, Sdafrika, den Vereinigten Arabischen Emiraten und im Vereinigten Knigreich. Besuchen Sie escalent.co, um zu sehen, wie wir dabei helfen, die Marken zu gestalten, die die Welt verndern.

ber C Space

C Space ist ein globales Unternehmen fr Kundenanalysen, –strategien und Innovation, die Kunden in die Arbeitsweise von Unternehmen integriert. C Space arbeitet mit den bekanntesten Marken der Welt zusammen, darunter Walmart, McDonald's und IKEA, und hilft seinen Kunden, Wachstum durch die Kraft menschlicher Beziehungen zu erzielen "" gemeinsam mit den Kunden statt fr sie, fr mehr Relevanz, strkere Bindung und einen hheren Customer Lifetime Value. Die Full–Service–Kundenlsungen von C Space sind auf die spezifischen Anforderungen der Unternehmen zugeschnitten, wobei der Schwerpunkt auf privaten Online–Communities, Co–Creation–Events, Workshops und leistungsstarker Storytelling– und Erkenntnis–Aktivierung liegt. C Space hat seinen Hauptsitz in Boston und unterhlt Bros in London, New York, San Francisco und Mexiko–Stadt.

ber Hall & Partners

Hall & Partners ist ein Team unkonventioneller Denkender, die sich damit beschftigen, wie Marketing die Beziehung zwischen Menschen, Marken und Kultur beeinflusst. Wir sind eine aus Adland hervorgegangene Insight–Agentur, die dafr bekannt ist, Kreativitt mit Wissenschaft zu verbinden. Wir destillieren Daten durch eine strategische Linse, um "ungewhnliche Einblicke" zu enthllen "" menschliche Wahrheiten, die auf einzelne Marken zugeschnitten sind, und keine Blackbox–Daten, die der Masse zur Verfgung stehen. Wir arbeiten mit unseren Kunden zusammen, um die Markenstrategie zu gestalten und die Marken– und Kampagnenleistung zu optimieren. Unser preisgekrnter Ansatz erweitert die Erkenntnisse ber alle Geschftsbereiche hinweg und frdert die Entscheidungsfindung im Marketing, um einen unbertroffenen Wettbewerbsvorteil zu schaffen. Hall & Partners hat seinen Hauptsitz in London und unterhlt Bros in New York, Los Angeles und Chicago.

Fotos zu dieser Mitteilung sind verfgbar unter:

https://www.globenewswire.com/NewsRoom/AttachmentNg/a9fa10fe–a141–4ab5–9823–af7a6ccf35c3

https://www.globenewswire.com/NewsRoom/AttachmentNg/fd85618f–f66f–4b47–957b–53e9fb689ffb


GLOBENEWSWIRE (Distribution ID 8806928)